CVS Health plans to split into two public companies by the first half of 2028, the company announced Wednesday. The plan would separate its roughly 9,000 retail pharmacies from its insurance business and its pharmacy benefit manager, Caremark.

CVS said the decision follows a "comprehensive strategic review" by its board of directors. Shares fell roughly 11% on Wednesday, according to CNBC.

The insurance and PBM company will keep the CVS Health name and remain under CEO David Joyner. The other company will be called CVS Pharmacy and will be led by Prem Shah, currently group president of CVS Health. CVS said additional leadership and board members will be announced later.

Joyner told CNBC's "Squawk on the Street" that the split comes "out of a position of strength." He pointed to recovery in Aetna's Medicare business and solid performance in retail pharmacy. CVS shares have risen roughly 70% since Joyner became CEO in October 2024, according to CNBC.

CVS also reported third-quarter earnings and revenue that topped Wall Street expectations. Total sales rose to $108.40 billion from $102.87 billion a year earlier. Revenue in the pharmacy services business declined from the prior year.

Joyner told analysts the two businesses' commercial relationship will continue through agreements between the companies. He said, "we don't need the integration of an operating structure."

Leerink Partners analyst Michael Cherny told CNBC the split reflects "the stability of the pharmacy." He said the company's CostVantage reimbursement model has helped stabilize gross margins.

Pharmacy benefit managers face scrutiny from lawmakers in Washington and several states. Tennessee and Arkansas have passed laws that would ban co-ownership of PBMs and pharmacies. CVS and other companies have challenged those laws in court.